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Dear Editor,
Herein, we report the first case of human infection with Ochro-
bactrum tritici, primarily isolated from environmental sources 
and not previously known to infect humans. A 70-yr-old male 
patient was admitted to a tertiary-care hospital for jaundice. He 
had a medical history of cholangiocellular carcinoma (CCC). On 
the first day of hospitalization, he presented a 38.1°C body tem-
perature, 98/81 mmHg blood pressure, 87 beats per minute 
heart rate, and abdominal distention. Laboratory findings indi-
cated a white blood cell count of 5.63×109/L with a differential 
of 71% neutrophils, a hemoglobin level of 10 g/dL, a platelet 
count of 25×109/L, and a C-reactive protein level of 48.5 mg/L 
(reference range, 0.1-6.0 mg/L). Two sets of blood cultures were 
performed at the time of high fever on admission. Among these 
four cultures, only one aerobic culture was positive for gram-
negative short rods after 4 days of incubation. Intravenous anti-
biotics with metronidazole (500 mg every 8 hr) and cefopera-
zone/sulbactam (2,000 mg every 12 hr) were started on the first 
day of hospitalization. His condition improved after antibiotic 
therapy and he was discharged from the hospital on day five. 
The isolate (named GNOT01) was identified as Ochrobactrum 
anthropi by matrix-assisted laser desorption ionization–time of 
flight mass spectrometer (MALDI-TOF MS; MicroFlex LT, Bruker 
Daltonics, Bremen, Germany).
Two weeks later, the patient presented with exacerbated jaun-
dice and abdominal pain. Physical examination revealed ab-
dominal distention and ascites. Laboratory analysis indicated a 
leukocyte count of 6.5×109/L with a differential of 71% neutro-
phils, a platelet count of 83×109/L, a C-reactive protein level of 
77.4 mg/L, and a total bilirubin of 6.7 mg/dL (reference range, 
0.3-1.8 mg/dL). He received intravenous cefoperazone/sulbac-
tam (2,000 mg every 12 hr) from the first day of hospitalization. 
Culture of the bile specimen collected during percutaneous 
transhepatic biliary drainage procedure yielded gram-negative 
rods (isolate GNOT02) and gram-positive cocci, identified as 
Ochrobactrum species and Enterococcus faecalis, respectively, 
by MALDI-TOF MS. The patient fully recovered from cholecysti-
tis without any evidence of infection and was discharged on day 
28 without specific complications. 
The clinical isolates, GNOT01 and GNOT02, were biochemi-
cally identified as O. anthropi with >99% probability. However, 
PCR and sequencing indicated that the 16S rRNA partial se-
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quences of both isolates were 100% identical to those of strain 
CCUG 47104T, the O. tritici type strain. Scanning electron mi-
croscopy (SEM) images of the isolates revealed that they had a 
single polar flagellum, which was not observed in the type strain 
CCUG 47104T (Fig. 1). On bacterial motility test using motility 
indole ornithine (MIO) agar, GNOT01 and GNOT02 showed up-
per stab lines that diffused out just beneath the surface of the 
MIO agar creating an umbrella-shape, which suggests that they 
are strictly aerobic and motile. No finding related to motility was 
obtained with CCUG 47104T. 
Pulsed-field gel electrophoresis (PFGE) presented identical 
XbaI macro-restriction banding patterns between the two iso-
lates, which were different from that of CCUG 47104T (similarity, 
84.2%) indicating that the bacteremia of the patient originated 
from cholecystitis.
Antimicrobial susceptibility testing showed that CCUG 47104T 
was susceptible to ticarcillin, ceftriaxone, and cefepime, while 
GNOT01 and GNOT02 were resistant to these antimicrobials. 
Extended-spectrum β-lactamase (ESBL) genes and plasmid-en-
coded AmpC β-lactamase genes were not detected in GNOT01 
and GNOT02 isolates by double disk synergy test and PCR, sug-
gesting that they acquired resistance to β-lactams not by produc-
tion of plasmid-mediated ESBLs or AmpC β-lactamases, but by 
overexpression of species-specific intrinsic AmpC β-lactamases.
To date, only four species, O. anthropi, O. intermedium, O. 
haematophilum, and O. pseudogrignonense, have been reported 
to cause human infections [1-4]. Among these, O. anthropi is 
the most frequently reported human pathogen, especially in im-
munocompromised patients. Phylogenetic analysis of 16S rRNA 
gene sequences revealed a high similarity between O. tritici and 
O. anthropi with 98% identity [5]. However, O. tritici strains ex-
hibit low DNA-DNA re-association values (< 60%) with O. an-
thropi probes and showed different phenotypic characteristics. 
These genotypic and phenotypic differences resulted in the 
classification of O. tritici as a distinct species. 
In summary, we reported the first case of human infection 
with an O. tritici motile strain isolated from the blood and bile. O. 
tritici should be considered as a potential pathogen that can 
cause bloodstream and biliary tract infections in humans. In ad-
dition, both commercial bacterial identification kits and MALDI-
TOF MS misidentified O. tritici clinical isolates as O. anthropic. 
Thus, 16S rRNA sequencing should be performed when a clini-
cal isolate is identified as O. anthropi by routine bacterial identi-
fication processes. 
Authors’ Disclosures of Potential Conflicts of 
Interest
No potential conflicts of interest relevant to this article were re-
ported.
Fig. 1. Scanning electron micrographs of Ochrobactrum tritici clinical isolate GNOT01 (A) and the type strain CCUG 47104T (B). GNOT01 
isolate presented a single polar flagellum, while CCUG 47104T strain did not (Magnification, ×20,000).
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